Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3690086014 | Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3690087017 | Triptorelin (as triptorelin acetate) 3.75 mg powder for suspension for injection syringe | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection | Is a | Product containing triptorelin | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection | Has presentation strength numerator value | 3.75 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection | Has unit of presentation | Syringe | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection | Has manufactured dose form | Powder for conventional release suspension for injection | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection | Has basis of strength substance | Triptorelin | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection | Has presentation strength denominator unit | Syringe | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection | Has precise active ingredient | Triptorelin acetate | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection | Is a | Product containing only triptorelin in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely triptorelin (as triptorelin acetate) 3.75 milligram/1 syringe powder for conventional release suspension for injection | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets